Coming soon

Get notified when accounts open

Accounts are not open yet. Leave your email and we will tell you the moment sign-up is available.

Jim Simons's UroGen Pharma Ltd. (URGN) position

Not anymore: Jim Simons fully exited URGN in Q1 2026. The position peaked at an amount we cannot price in Q1 2022.
View full portfolio →
Value at exit
an amount we cannot price
Shares at exit
244K
Quarter-end price
No quarter-end price available

Average buy price is hidden here because at least one covered purchase quarter has no usable local mean price.

URGN price vs Simons's position

1Y 3Y 5Y MAX
Dates
← Earlier —8 purchases, 5 sells35404550
Average closing price · filing quarter
—
Price range · filing quarter
—
Get notified when accounts open

Every quarterly change

Every quarterly change
Quarter Action Shares change Est. value change Δ Own Shares held Filing date
Exited· Q1 2026 −244K
Quarter Q1 2026 Δ Own −100.0% Shares held 0 Filing date May 14, 2026
Q1 2026 Exited· Q1 2026 −244K – −100.0% 0 May 14, 2026
Reduced· Q4 2025 −31K
Quarter Q4 2025 Δ Own −11.2% Shares held 244K Filing date Feb 12, 2026
Q4 2025 Reduced· Q4 2025 −31K – −11.2% 244K Feb 12, 2026
Added· Q3 2025 +237K
Quarter Q3 2025 Δ Own +620.2% Shares held 275K Filing date Nov 13, 2025
Q3 2025 Added· Q3 2025 +237K – +620.2% 275K Nov 13, 2025
Reduced· Q2 2025 −52K
Quarter Q2 2025 Δ Own −57.8% Shares held 38K Filing date Aug 13, 2025
Q2 2025 Reduced· Q2 2025 −52K – −57.8% 38K Aug 13, 2025
Reduced· Q1 2025 −48K
Quarter Q1 2025 Δ Own −34.4% Shares held 91K Filing date May 14, 2025
Q1 2025 Reduced· Q1 2025 −48K – −34.4% 91K May 14, 2025
New· Q4 2024 +138K
Quarter Q4 2024 Shares held 138K Filing date Feb 13, 2025
Q4 2024 New· Q4 2024 +138K – – 138K Feb 13, 2025
Reduced· Q4 2023 −69K
Quarter Q4 2023 Δ Own −43.0% Shares held 91K Filing date Feb 13, 2024
Q4 2023 Reduced· Q4 2023 −69K – −43.0% 91K Feb 13, 2024
Added· Q3 2023 +86K
Quarter Q3 2023 Δ Own +116.6% Shares held 160K Filing date Nov 14, 2023
Q3 2023 Added· Q3 2023 +86K – +116.6% 160K Nov 14, 2023
Added· Q2 2023 +26K
Quarter Q2 2023 Δ Own +54.2% Shares held 74K Filing date Aug 11, 2023
Q2 2023 Added· Q2 2023 +26K – +54.2% 74K Aug 11, 2023
Added· Q1 2023 +5K
Quarter Q1 2023 Δ Own +10.9% Shares held 48K Filing date May 12, 2023
Q1 2023 Added· Q1 2023 +5K – +10.9% 48K May 12, 2023
Added· Q4 2022 +200
Quarter Q4 2022 Δ Own +0.5% Shares held 43K Filing date Feb 13, 2023
Q4 2022 Added· Q4 2022 +200 – +0.5% 43K Feb 13, 2023
Reduced· Q3 2022 −500
Quarter Q3 2022 Δ Own −1.1% Shares held 43K Filing date Nov 14, 2022
Q3 2022 Reduced· Q3 2022 −500 – −1.1% 43K Nov 14, 2022
Added· Q2 2022 +19K
Quarter Q2 2022 Δ Own +76.5% Shares held 44K Filing date Aug 12, 2022
Q2 2022 Added· Q2 2022 +19K – +76.5% 44K Aug 12, 2022
New· Q1 2022 +25K
Quarter Q1 2022 Shares held 25K Filing date May 13, 2022
Q1 2022 New· Q1 2022 +25K – – 25K May 13, 2022
Data through Q1 2026 · filed May 14, 2026
14 of 14

More Simons positions

United Therapeutics Corporation(UTHR)
$1.1B
1.7% of portfolio

Palantir Technologies Inc.(PLTR)
$997M
1.6% of portfolio

Apple Inc.(AAPL)
$778M
1.2% of portfolio

Kinross Gold Corporation(KGC)
$780M
1.2% of portfolio

Micron Technology, Inc.(MU)
$731M
1.1% of portfolio

VeriSign, Inc.(VRSN)
$700M
1.1% of portfolio

Common questions

Does Jim Simons own URGN?

Not currently. Jim Simons fully exited URGN in Q1 2026, and the complete history is above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

When did Jim Simons buy URGN?

Jim Simons first disclosed a URGN position in Q1 2022; every quarterly buy and sell since is in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

Did Jim Simons sell URGN?

Yes. Jim Simons reduced and then fully exited URGN by Q1 2026; the reductions are in the table above. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How many shares of URGN does Jim Simons own?

None as of the latest filing: Jim Simons has exited URGN. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

What price did Jim Simons pay for URGN?

Jim Simons began building the URGN position before our 13F history starts, so an exact average buy price cannot be estimated without understating it. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.

How are the estimated trade prices calculated?

13F filings disclose quarter-end holdings, not trade dates or execution prices. These estimates use each covered quarter's average market price; the add average excludes the opening position and quarters without price data. All figures come from SEC 13F filings for Q1 2026, the latest disclosed quarter.